Julie V. Philley

The University of Texas Health Science Center at Tyler

MedicineBiochemistry, Genetics and Molecular BiologyVeterinaryChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease”.

Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease

CHEST Journal(2023)10.1016/j.chest.2023.05.036

N/A

0.965DataRank · unranked

24 citations

David E. Griffith, Julie V. Philley, Barbara A. Brown‐Elliott, Amanda E. Brunton, Peter E. Sullivan +5 more

Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease

CHEST Journal(2023)10.1016/j.chest.2023.02.015

N/A

0.788DataRank · unranked

19 citations

Alexandra L. Quittner, Nathan F. Dieckmann, Heather Franklin, Amanda E. Brunton, Charles L. Daley +56 more

Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01080-23

N/A

0.292DataRank · unranked

6 citations

Tawanda Gumbo, Gunavanthi D. Boorgula, Tania A. Thomas, Julie V. Philley, Shashikant Srivastava +1 more

COVID-19 Convalescent Plasma Therapy: Long-term Implications

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad686

N/A

0DataRank · unranked

3 citations

Yi Li, Keith Goldfeld, Gia Cobb, Caroline L Sturm-Reganato, Luis Ostrosky‐Zeichner +68 more